Cargando…

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience

Detalles Bibliográficos
Autores principales:	Karimi, Mehran, Haghpanah, Sezaneh, Azarkeivan, Azita, Matin, Sara, Safaei, Arash, De Sanctis, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2021
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813286/ https://www.ncbi.nlm.nih.gov/pubmed/33489047 http://dx.doi.org/10.4084/MJHID.2021.008

Ejemplares similares

Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β -Thalassemia Patients and effects of Associated Comorbidities: An Iranian Nationwide study
por: Karimi, Mehran, et al.
Publicado: (2020)

Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report
por: Karimi, Mehran, et al.
Publicado: (2022)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia
por: Majd, Zahra, et al.
Publicado: (2015)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2018)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2010)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2015)

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014)

Comparative Study of Radiographic and Laboratory Findings Between Beta Thalassemia Major and Beta Thalassemia Intermedia Patients With and Without Treatment by Hydroxyurea
por: Abolhasani Foroughi, Amin, et al.
Publicado: (2015)

The Diagnostic Approach to Central Adrenocortical Insufficiency (CAI) in Thalassemia
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea
por: Khavari, Maryam, et al.
Publicado: (2014)

A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population
por: Maryami, Fereshteh, et al.
Publicado: (2015)

Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia
por: Haghpanah, Sezaneh, et al.
Publicado: (2022)

PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT
por: Karimi, M., et al.
Publicado: (2022)

Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients
por: Hashemieh, Mozhgan, et al.
Publicado: (2017)

Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study
por: Bordbar, Mohammadreza, et al.
Publicado: (2017)

Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran
por: Karimi, Mehran, et al.
Publicado: (2016)

Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years’ Experience
por: Safarpour, Mohammad Mostafa, et al.
Publicado: (2017)

Economic Burden of Thalassemia Major in Iran, 2015
por: Esmaeilzadeh, Firooz, et al.
Publicado: (2016)

Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the “high clinical risk” category?
por: Karimi, Mehran, et al.
Publicado: (2020)

Hemoaction Game: An educational Step to Improve Hemophilia Children and Nurses Self-Efficacy
por: BEHESHTIPOOR, NOOASHIN, et al.
Publicado: (2016)

Termination of pregnancy due to Thalassemia major, Hemophilia, and Down's Syndrome: the views of Iranian physicians
por: Karimi, Mehran, et al.
Publicado: (2008)

Inherited Thrombophilia and Recurrent Pregnancy Loss
por: Parand, Alireza, et al.
Publicado: (2013)

Management of Bleeding in Post-liver Disease, Surgery and Biopsy in Patients With High Uncorrected International Normalized Ratio With Prothrombin Complex Concentrate: An Iranian Experience
por: Parand, Alireza, et al.
Publicado: (2013)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
por: Zarghamian, Parinaz, et al.
Publicado: (2020)

Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia
por: Azarkeivan, Azita, et al.
Publicado: (2009)

Effect of quercetin on oxidative stress and liver function in beta-thalassemia major patients receiving desferrioxamine: A double-blind randomized clinical trial
por: Sajadi Hezaveh, Zohreh, et al.
Publicado: (2019)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017)

Serum cancer antigen 15.3 concentrations in patients with betathalassemia minor compared to those with cancer and healthy individuals
por: Shahriari, Mahdi, et al.
Publicado: (2014)

Epidemiologic study of patients with thrombotic events referred to a tertiary hospital in Southern Iran
por: Akbari, Ahmad, et al.
Publicado: (2021)

The impact of inhibitors on the quality of life in patients with hemophilia
por: Haghpanah, Sezaneh, et al.
Publicado: (2023)

Red Blood Cell Immunization and Contributing Factors in 685 Thalassemia Patients
por: Shaiegan, Mojgan, et al.
Publicado: (2022)

Survival analysis of thalassemia major patients using Cox, Gompertz proportional hazard and Weibull accelerated failure time models
por: Bakhshi, Enayatollah, et al.
Publicado: (2017)

Antithrombotic prophylaxis in children and adolescent patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians
por: Karimi, Mehran, et al.
Publicado: (2020)

Blood group genotyping in alloimmunized multi‐transfused thalassemia patients from Iran
por: Sarihi, Reyhaneh, et al.
Publicado: (2021)

Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

The survival of childhood leukemia: An 8‐year single‐center experience
por: Bordbar, Mohammadreza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_39qhplk7a33o1j1911l3vt2k0v